Page last updated: 2024-09-03

n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine and Arterial Occlusive Diseases

n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine has been researched along with Arterial Occlusive Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bator, JM; Burch, RM; Cameron, DE; Curtis, WE; Gardner, TJ; Gillinov, AM; Wilson, IC1

Other Studies

1 other study(ies) available for n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine and Arterial Occlusive Diseases

ArticleYear
Inhibition of neutrophil adhesion reduces myocardial infarct size.
    The Annals of thoracic surgery, 1993, Volume: 56, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Arterial Occlusive Diseases; Cell Adhesion Molecules; Infusions, Intravenous; Leucine; Models, Biological; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Risk Factors; Swine; Time Factors

1993